# Topical Safety Study of Topical Diltiazem Hydrochloride

> **NCT01816529** · PHASE1 · UNKNOWN · sponsor: **Ventrus Biosciences, Inc** · enrollment: 200 (estimated)

## Conditions studied

- Diltiazem Skin Sensitivity.

## Interventions

- **DRUG:** Diltiazem Hydrochloride 2% Cream
- **DRUG:** Vehicle Cream
- **DRUG:** 0.1% solution of sodium lauryl sulfate (SLS)
- **DRUG:** Saline (0.9%)

## Key facts

- **NCT ID:** NCT01816529
- **Lead sponsor:** Ventrus Biosciences, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2013-06
- **Final completion:** 2013-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2013-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01816529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01816529, "Topical Safety Study of Topical Diltiazem Hydrochloride". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01816529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*